MGCLF News and Press, MGC Pharmaceuticals Ltd From 04/05/22

MGC Pharmaceuticals Enters Partnership with Sciensus Rare for Distribution of Cannabinoids to Treat Refractory Epilepsy, Dementia and Alzheimer's in the EU and UK PR Newswire LONDON , April 5, 2022 /PRNewswire/ -- MGC Pharmaceuticals Ltd. (LSE: MXC, A...

Mexico with 121 million citizens will likely legalize cannabis by April of this year opening the door to the largest population for potential customers; This will be a game-changing tipping point for legalization of cannabis around the world and especially throughout Latin America; ...

Cannabis sales are determined by number of dispensaries and the availability to them by proximity. California has no restrictions regarding the number of dispensaries such as Washington State. Growth in cannabis in California will eclipse the entire cannabis industry's current ret...

Cannabis companies are starting to turn a profit and print positive EPS. Here are the few that are earning a profit. Many companies are close to turning a positive EPS. The industry itself is expected to expand some 100% in the next couple of years, and with economies of scale, th...

Click here to read the previous Australian cannabis outlook. The Australian cannabis market is moving along as regulations fall into place for the sector to keep expanding. While the current rules may make the market appear at a standstill, recent approvals show the mome...

Medical cannabis companies THC Global Group (ASX: THC ) and MGC Pharmaceuticals (ASX: MXC ,OTCQB:MGCLF) are teaming up through a new supply agreement. Monday’s (January 20) announcement confirms that MGC Pharma will be tasked with providing THC Global with additional medical cannabi...

The following slide deck was published by MGC Pharmaceuticals Limited in conjunction with this Read more ...

NEW YORK, June 12, 2019 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has recently published interviews with CEO’s of trending stocks in the CBD and hemp consumer products space ahead of new state legislation expected to pass in California t...

MGC Pharmaceuticals Ltd ( OTCPK:MGCLF ): FY GAAP EPS of $0.05. Revenue of $0.29M (+866.7% Y/Y) Press Release More news on: MGC Pharmaceuticals Ltd, Earnings news and commentary, Healthcare stocks news, ,

Out of over 200+ marijuana stocks , here are 5 of the biggest marijuana stock winners in trading on Wednesday, August 8th including Insys Therapeutics Inc. (NASDAQ:INSY) and more... Insys Therapeutics Inc. (NASDAQ:INSY) Shares of Insys Therapeutics Inc. rose 17.14% on higher than averag...